Tell the Medical Director before the service is marketed or launched. A new medication, procedure, device, pharmacy source, practitioner, or clinical workflow can change the governance structure the physician originally accepted — so it needs to be reviewed and built in first, not discovered afterward.
Open the full explanation2 sections and primary sources
What changes should trigger a call to the Medical Director?
A new clinical service, a new drug or product, a new route/procedure/device, a pharmacy or source change, a new prescriber, a new location, a controlled substance, or a major workflow change all warrant a conversation before go-live.
Why bring the Medical Director in before a new line launches?
Bringing the director in early is how a new line launches on a compliant footing. See how MFMD helps structure a new line at /service-line-setup.